|
|
Article: Medtronic Third Quarter Revenue up 12 Percent to $3.405 Billion.(Financial report)
- Article from:
- Business Wire
- Article date:
- February 19, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
* ICD Revenue of $726 million;
* GAAP EPS of $0.07; Non-GAAP EPS of $0.63;
* Kyphon acquisition contributed $147 million in revenue for the quarter;
* Endeavor[R] drug-eluting stent approved in U.S. on February 1, 2008
MINNEAPOLIS -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its fiscal third quarter, which ended January 25, 2008.
Medtronic recorded third quarter revenue of $3.405 billion, a 12 percent increase over the $3.048 billion reported in the third quarter of fiscal year 2007. Non-U.S. revenue of $1.307 billion grew 20 percent, including a $117 million benefit from currency translation, and ...